Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Regulatory News & FDA Approvals › NYS Gives Final Approval for Rosetta Genomics' Thyroid Cancer Test

NYS Gives Final Approval for Rosetta Genomics' Thyroid Cancer Test

May 04, 2017
|
staff reporter

NEW YORK (GenomeWeb) – Rosetta Genomics today announced New York State has given final approval for the RosettaGx Reveal thyroid cancer test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Regulatory News & FDA Approvals

  1. Color Health, Yale Get FDA Emergency Use Authorization for Coronavirus Sample Collection Kits

  2. Australian Firm AnteoTech Obtains CE Marking for COVID-19 Antigen Test, Reader

  3. Lucira Health Nabs OTC EUA for SARS-CoV-2 Test, Expects Q1 Revenues of up to $4.5M

  4. Thermo Fisher Scientific Gets FDA EUA for High-Throughput, Automated COVID-19 Test Kit

  5. Siemens Healthineers Gets CE Mark for Point-of-Care High-Sensitivity Cardiac Troponin I Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.